News Novo to expand world's biggest insulin production site World's largest insulin plant is to get bigger.
News FDA panel narrowly backs heart benefit of BI/Lilly diabetes ... FDA advisers voted 12-11 that Jardiance also reduces cardiovascular risks.
News Diabetes wearable and VR platform winners at Healthtech Summ... Insulin delivery wearable and neuro-rehabilitation virtual reality scoop top awards.
News Abbott’s needleless diabetes platform as effective as self-m... Study demonstrates a 38% reduction in time spent in hypoglycaemia, compared to traditional self monitoring.
News Victoza disappoints on cardio benefits, lifts rival Jardianc... Victoza results are significant, but fell short of investors' expectations.
News Sanofi's diabetes combo on target for showdown with Novo Rival insulin and GLP-1 combinations under review in US.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
